We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Novartis Hits Par With Second Lotrel Suit

Law360 (January 4, 2007, 12:00 AM EST) -- Swiss pharmaceutical giant Novartis International AG has filed another patent suit against Par Pharmaceuticals, seeking to protect the market for billion-dollar hypertension treatment Lotrel.

The latest lawsuit, filed on December 29...
To view the full article, register now.